abstract |
The present invention is directed to compounds of formula (I) and salts acceptable for pharmaceutical use, esters, and prodrugs thereof that are Factor Xa inhibitors. The present invention is also directed to intermediate products used in the realization of said compounds, pharmaceutical compositions containing said compounds, methods for preventing or treating various conditions characterized by unwanted thrombosis and methods of inhibiting coagulation of a blood sample. |